These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34801547)

  • 1. Molecular and in vivo phenotyping of missense variants of the human glucagon receptor.
    van der Velden WJC; Lindquist P; Madsen JS; Stassen RHMJ; Wewer Albrechtsen NJ; Holst JJ; Hauser AS; Rosenkilde MM
    J Biol Chem; 2022 Feb; 298(2):101413. PubMed ID: 34801547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
    J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification and preliminary characterization of glucagon receptor extracellular domain.
    Wu L; Zhai Y; Lu J; Wang Q; Sun F
    Protein Expr Purif; 2013 Jun; 89(2):232-40. PubMed ID: 23597780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles.
    Conley JM; Sun H; Ayers KL; Zhu H; Chen R; Shen M; Hall MD; Ren H
    J Biol Chem; 2021 Jul; 297(1):100881. PubMed ID: 34144038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
    Estall JL; Koehler JA; Yusta B; Drucker DJ
    J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling.
    Cegla J; Jones BJ; Gardiner JV; Hodson DJ; Marjot T; McGlone ER; Tan TM; Bloom SR
    Endocrinology; 2017 Aug; 158(8):2680-2693. PubMed ID: 28586439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-molecule analysis reveals that a glucagon-bound extracellular domain of the glucagon receptor is dynamic.
    Liu T; Khanal S; Hertslet GD; Lamichhane R
    J Biol Chem; 2023 Sep; 299(9):105160. PubMed ID: 37586587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic β-arrestin 2 is essential for maintaining euglycemia.
    Zhu L; Rossi M; Cui Y; Lee RJ; Sakamoto W; Perry NA; Urs NM; Caron MG; Gurevich VV; Godlewski G; Kunos G; Chen M; Chen W; Wess J
    J Clin Invest; 2017 Aug; 127(8):2941-2945. PubMed ID: 28650340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.
    Jorgensen R; Martini L; Schwartz TW; Elling CE
    Mol Endocrinol; 2005 Mar; 19(3):812-23. PubMed ID: 15528268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
    Wang H; Hu W; Liu D; Wüthrich K
    FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitination status of the glucagon receptor determines signal bias.
    Kaur S; Sokrat B; Capozzi ME; El K; Bai Y; Jazic A; Han B; Krishna Kumar K; D'Alessio DA; Campbell JE; Bouvier M; Shenoy SK
    J Biol Chem; 2023 May; 299(5):104690. PubMed ID: 37037304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation.
    Schelshorn D; Joly F; Mutel S; Hampe C; Breton B; Mutel V; Lütjens R
    Mol Pharmacol; 2012 Mar; 81(3):309-18. PubMed ID: 22108912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates
    Senatorov IS; Cheshmehkani A; Burns RN; Singh K; Moniri NH
    Mol Pharmacol; 2020 May; 97(5):304-313. PubMed ID: 32132133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of β-catenin signaling by glucagon receptor activation.
    Ke J; Zhang C; Harikumar KG; Zylstra-Diegel CR; Wang L; Mowry LE; Miller LJ; Williams BO; Xu HE
    PLoS One; 2012; 7(3):e33676. PubMed ID: 22438981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
    Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
    J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling.
    McGlone ER; Manchanda Y; Jones B; Pickford P; Inoue A; Carling D; Bloom SR; Tan T; Tomas A
    Mol Metab; 2021 Nov; 53():101296. PubMed ID: 34271220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tail engagement of arrestin at the glucagon receptor.
    Chen K; Zhang C; Lin S; Yan X; Cai H; Yi C; Ma L; Chu X; Liu Y; Zhu Y; Han S; Zhao Q; Wu B
    Nature; 2023 Aug; 620(7975):904-910. PubMed ID: 37558880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Glycosphingolipid GM3 Modulates Conformational Dynamics of the Glucagon Receptor.
    Ansell TB; Song W; Sansom MSP
    Biophys J; 2020 Jul; 119(2):300-313. PubMed ID: 32610088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.